NOVATUS
DEAD

Serial Number

98164070

Owner

NOVATUS GLOBAL LTD

Attorney

Marek Krizka

First Use Date

Mar 28, 2019

Filing Date

Sep 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOVATUS Trademark

Serial Number: 98164070

NOVATUS is a trademark filed by NOVATUS GLOBAL LTD on September 5, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NOVATUS GLOBAL LTD (3 trademarks)

60-62 Margaret Street
London W1W 8TF , GB

Entity Type: 11

Trademark Details

Filing Date

September 5, 2023

Registration Date

Not Registered

First Use Anywhere

March 28, 2019

First Use in Commerce

December 16, 2022

Goods & Services

Financial advisory and consultancy services; Financial management; Financial risk management; Investment management; Investment risk assessment services; Strategic financial advisory services; all of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products

Assistance, advisory services and consultancy with regard to business planning, business analysis, business management, and business organization; Business analysis and business strategic planning services in the technology industry; Business risk assessment services; Business risk management services; Consultancy and advisory services in the field of business strategy; Government relations consultancy services; Planning, development, maintenance, tracking and reporting of online marketing activities for third parties; Providing information and news in the field of business, namely, information and news on current events and on economic, legislative, and regulatory developments as it relates to and can impact businesses; Regulatory submission management, namely, assisting others in preparing and filing applications for financial services authorizations with governmental regulatory bodies; all of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products

Consulting and legal services in the field of privacy and security laws, regulations, and requirements; Information, advisory and consultancy services relating to legal matters; Legal advisory services; Legal compliance auditing; Legal services; Providing information about legal services via a website; Regulatory compliance auditing; Regulatory compliance consulting in the field of environment and finance; Reviewing standards and practices to assure compliance with financial laws and regulations; all of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products

Computer software design; Computer software development; Computer software installation and maintenance; Hosting of digital content on the Internet; Planning, design and management of information technology systems; Providing temporary use of on-line non-downloadable software and applications for regulatory compliance management, operational efficiency optimization, and technology-driven support; Software as a service (SAAS) services featuring software for regulatory compliance management, operational efficiency optimization, and technology-driven support; all of the aforesaid services only directed to financial services firms and none of the aforesaid services relating to the development, production and offering of pharmaceuticals, medical or healthcare products, including services to obtain authorisation and approval for the marketing of such products

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 10, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 10, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 21, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 21, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2024 CNRT
ASSIGNED TO EXAMINER
May 1, 2024 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 20, 2023 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 20, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2023 NWOS
NEW APPLICATION ENTERED
Sep 5, 2023 NWAP